Genes & pathways

Gene & pathway reference · FROM DR. PURSER’S TEACHING

CCL4

CCL4 encodes MIP-1 beta, a chemokine involved in attracting immune cells. It participates in a recruitment network that includes CCL2, CXCL8 and related chemokines.

Updated Sep 23, 2026 · Educational reference

THE TEACHING CONNECTION

MIP-1 beta and overlapping recruitment signals

MIP-1 beta and overlapping recruitment signals

CCL4 encodes MIP-1 beta, a chemokine involved in attracting immune cells. It participates in a recruitment network that includes CCL2, CXCL8 and related chemokines.

How Dr. Purser connects the pieces

Dr. Purser connects CCL4 with late-phase allergic activity and with the vascular inflammatory network discussed in his homocysteine model. The updated panel removes a previously misassigned marker, rs11079929; it should not be treated as a CCL4 result. The teaching connection remains useful without that erroneous mapping.

Where the VARS Triad and MTHFR Daily fit

In Dr. Purser’s treatment framework, the VARS Triad—VARS Glutathione, VARS SOD and VARS Catalase—together with MTHFR Daily is a central consideration when homocysteine or cytokine issues are involved. He emphasizes VARS Glutathione as a foundational functional-support component across his genetic SNP teaching. The individual gene lesson explains how its pathway connects to that broader approach.

This describes the Purser treatment model, not proof that a product corrects a variant or treats every associated condition. Product choice, formulation, sequence and amount depend on the individual assessment, existing medicines, current findings and tolerance.

A question to bring to your visit

Has the gene-to-variant mapping been checked, and what clinical allergic or vascular findings are relevant?

Variant lookup

These teaching identifiers include regional research markers. Match them to your original laboratory report; listing alone does not establish clinical significance or a treatment need.

Names you may see

MIP-1 beta · MIP-1β